|
Join Us in Welcoming Our New CEO
We are thrilled to welcome Ms. Angelique Berg as the new CEO of Hypertension Canada as of January 27, 2014. Angelique is a business development and marketing executive with over 15 years of experience spanning both the profit and non-profit health sectors. Her leadership experience includes roles in public and government relations, program and volunteer management, and over 10 years in fundraising. She is known for her dedication to excellence in charitable management, and for her passion to improve health for a thriving, productive society. |
|
IN FOCUS
2014 CHEP Recommendations
 On behalf of the Canadian Hypertension Education Program Recommendations Task Force, we are pleased to announce the completion of the 2014 CHEP Recommendations. 2014 is a key milestone for CHEP and Hypertension Canada as it marks the 15th consecutive year that CHEP has updated our recommendations for the management of hypertension.
CHEP's evidence-based recommendations are developed annually through intense discussion of the clinical implications via a systematic review of the literature followed by critical appraisals of all the new clinical research and taking into account the assessment criteria in the AGREE II instrument. AGREE II stands for The Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument, which evaluates the process of practice guideline development and the quality of reporting. Read more about CHEP recommendations process and AGREE II assessment here.
In 2014, new CHEP recommendations provide updated guidance for the treatment of the very elderly, patients with ischemic heart disease and for the use of acetylsalicylic acid for primary prevention. In addition, new sodium intake thresholds are proposed and A1c testing is has been added as a recommended test for diabetes screening.
In order to facilitate the dissemination of the 2014 CHEP recommendations, we continue to emphasize these seven key messages:
- All Canadian adults should have their blood pressure assessed at all appropriate clinical visits.
- Optimum management of the hypertensive patient requires assessment and communication of overall cardiovascular risk.
- Home BP monitoring is an important tool in self-monitoring and self-management.
- Treat to target.
- Lifestyle modifications are effective in preventing hypertension, treating hypertension and reducing cardiovascular risk.
- Comibinations of both lifestyle changes and drugs are generally necessary to achieve target blood pressures.
- Focus on adherence.
For more details check out our NEW One Page Summary.
Our educational tools are updated annually to reflect these changes. For the latest tools and updates, please visit the Hypertension Canada website.
Raj Padwal, MD, MSc & Luc Poirier, BPharm, MSc
Co-Chairs, CHEP |
|
|
|
Up & Up
Update & Upcoming Events | |
|
January 22 - 25, 2014
SQHA Annual Scientific Meetings Quebec City, Quebec
May 17, 2014
World Hypertension Day
May 16, 2014 - May 20, 2014
ASH Annual Scientific Meeting & Exposition
Hilton New York, New York
June 13-16, 2014
25th Scientific Meeting of the International Society of Hypertension (joint with European Society of Hypertension)
Athens, Greece
October 16 - 19, 2014
Canadian Hypertension Congress
Château Cartier, Gatineau, Québec
|
|
What's New on the Website | |
|
|
